Last reviewed · How we verify
Abnormal uterine bleeding due to uterine fibroid
Approved treatments
- Orgovyx · MYOVANT SCIENCES
Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Abnormal uterine bleeding due to uterine fibroid patent landscape — cliff calendar, originator estates, attackable patents
- Abnormal uterine bleeding due to uterine fibroid treatment landscape brief
- Abnormal uterine bleeding due to uterine fibroid treatment updates RSS
Frequently asked questions about Abnormal uterine bleeding due to uterine fibroid
What drugs treat Abnormal uterine bleeding due to uterine fibroid?
Tracked treatments include Orgovyx.
What is the treatment for Abnormal uterine bleeding due to uterine fibroid?
Standard treatment for Abnormal uterine bleeding due to uterine fibroid includes Orgovyx. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Abnormal uterine bleeding due to uterine fibroid patent cliff · Abnormal uterine bleeding due to uterine fibroid CI report
- Treatment: Orgovyx · MYOVANT SCIENCES
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing